We are watching these cases closely...Our team of defective drug attorneys have taken a special interest in this litigation and are now available to investigate potential similar claims.
San Diego, CA (PRWEB) March 27, 2015
In light of two lawsuits that were filed in February 2015 (case number 1:15-cv-10429, U.S. District Court, District of Massachusetts; and case number 2:15-cv-00709PD, United States District Court of the Eastern District of Pennsylvania), the San Diego personal injury lawyers of The Law Office of Melinda J. Helbock, A.P.C. are announcing that they are available to investigate potential birth defect lawsuits on behalf of women who were prescribed Zofran while pregnant and who gave birth to babies with various congenital defects. In case number 1:15-cv-10429, the plaintiffs allege GlaxoSmithKline failed to inform the public about important safety information possibly linking Zofran to birth defects and wrongfully promoting the drug for the off-label treatment of nausea and vomiting in pregnant women.
According to case number 1:15-cv-10429, Glaxo was aware that Zofran could cross the placenta barrier, posing potential dangers to developing babies as early as the 1980s. The lawsuit also alleges the drug maker failed to inform the public about results from animal studies which showed the drug resulted in intrauterine deaths and malformations in offspring.
“We are watching these cases closely,” said Melinda Helbock, founder of The Law Office of Melinda J. Helbock, A.P.C. “The allegations against Glaxo for its handling of potential Zofran side effects are serious and the outcome of these cases will help set the precedence for future similar lawsuits. Our team of defective drug attorneys have taken a special interest in this litigation and are now available to investigate potential similar claims.”
Zofran (ondansetron), which belongs to class of medications known as 5-HT3 receptor antagonists, is prescribed to prevent nausea and vomiting caused by cancer patients receiving chemotherapy or radiation, and is also used to prevent nausea or vomiting after surgery. It is not approved for use by pregnant or nursing women.
Women who were prescribed Zofran during their pregnancies and who gave birth to children with congenital defects may be entitled to file their own claims against GlaxoSmithKline. For more information, visit helbocklaw.com or call 1-800-543-8940.
The Law Office of Melinda J. Helbock, A.P.C.
The Law Office of Melinda J. Helbock, A.P.C. is a San Diego-based personal injury law firm that handles birth defect claims on behalf of babies and families that are struggling with various birth defects as a result of medications prescribed during pregnancy. Our attorneys are now investigating potential Zofran birth defect claims and can be reached at 1-800-543-8940.